1-6 of 6
Zafar Siddiqui
Close
Sort by
Journal Articles

Differential Modulation of Plasminogen Activator Mediated Thrombolysis By Recombinant Thrombomodulin and Activated Protein C

Jawed Fareed, PhD, Zafar Siddiqui, Sanchayana Raghuvir, Sid Mehrota, Omer Iqbal, Walter Jeske, Debra Hoppensteadt, PhD, Kosuke Tanaka, Kazuhisa Tsuruta
Journal: Blood
Blood (2017) 130 (Supplement 1): 4865.
https://doi.org/10.1182/blood.V130.Suppl_1.4865.4865
Published: 2017
Journal Articles

Comparative Studies on a Branded Recombinant Factor VIIa and Its Generic Version to Demonstrate Bioequivalence

Nasir Sadeghi, Zafar Siddiqui, Omer Iqbal, Schuharazad Abro, Debra Hoppensteadt, PhD, Michael Mosier, Jeanine Walenga, Jawed Fareed, PhD, Ahmed Kouta
Journal: Blood
Blood (2017) 130 (Supplement 1): 4868.
https://doi.org/10.1182/blood.V130.Suppl_1.4868.4868
Published: 2017
Journal Articles

Anticoagulant Actions of Recombinant Thrombomodulin and Activated Protein C and Their Neutralization By Factor VIII Inhibitor Bypass Activity (FEIBA)

Walter Jeske, Mary Lewis, Parul Aggarwal, Zafar Siddiqui, Omer Iqbal, Debra Hoppensteadt, PhD, Kazuhisa Tsuruta, Jawed Fareed, PhD, Sid Mehrota
Journal: Blood
Blood (2017) 130 (Supplement 1): 4905.
https://doi.org/10.1182/blood.V130.Suppl_1.4905.4905
Published: 2017
Journal Articles

Comparative Studies on the Anticoagulant Actions of Recombinant Thrombomodulin and Heparin and Their Neutralization By FEIBA As Measured By Thromboelastography

Parul Aggarwal, Zafar Siddiqui, Omer Iqbal, MD, Walter Jeske, PhD, Debra Hoppensteadt, PhD, Kazuhisa Tsuruta, PhD, Jawed Fareed, PhD, Mary Lewis
Journal: Blood
Blood (2016) 128 (22): 2608.
https://doi.org/10.1182/blood.V128.22.2608.2608
Published: 2016
Journal Articles

Comparative Anticoagulant Effects of Recombinant Thrombomodulin, Antithrombin, and Unfractionated Heparin, Hematological Implications

Zafar Siddiqui, Parul Aggarwal, Omer Iqbal, MD, Debra Hoppensteadt, PhD, Mary Lewis, Schuharazad Abro, MD, Kazuhisa Tsuruta, PhD, Jawed Fareed, PhD
Journal: Blood
Blood (2016) 128 (22): 4974.
https://doi.org/10.1182/blood.V128.22.4974.4974
Published: 2016
Journal Articles

Dabigatran Neutralizing Antobody, Idarucizumab, Exhibits Procoagulant and Platelet Activation Responses in Whole Blood. Potential Clinical Implications

Zafar Siddiqui, Omer Iqbal, MD, Debra Hoppensteadt, PhD, Mary Lewis, Rohan Rege, Schuharazad Abro, MD, Jawed Fareed, PhD
Journal: Blood
Blood (2016) 128 (22): 2622.
https://doi.org/10.1182/blood.V128.22.2622.2622
Published: 2016